A medicated weight loss plan can be a useful tool for reaching your goals, provided it is used alongside a healthy diet and positive lifestyle choices. While there are no quick fixes, GLP-1 medications such as Wegovy and Mounjaro could lead to average weight reductions of 20.7% and 22.5%, respectively.
One potential downside of these treatments, however, is that they are usually self-administered subcutaneous (under the skin) injections. This may make them unsuitable for people who have a phobia of needles or are put off by the thought of injecting themselves. This landscape changed in June 2026, when UK regulators approved an oral Wegovy tablet for weight loss.
While not yet available, this new Wegovy oral tablet could be a positive alternative to the injections and make weight loss more achievable for some people. But what exactly is this Wegovy pill, how does it work, and how effective is it? Join us as we explain it all.
The Wegovy pill is a once-daily weight loss medication that was approved by the Medicines and Healthcare products Regulatory Agency (MHRA) on 11 June 2026 for obese or overweight adults with weight-related health conditions. The Wegovy tablet is the first glucagon-like peptide-1 receptor agonist pill approved in the UK specifically for weight management.
The tablet contains semaglutide, the same active ingredient found in Wegovy injections. However, instead of being taken once weekly, the Wegovy pill is taken orally once a day.
The approval of the Wegovy tablet means the UK is the first country in Europe to approve the treatment and only the third country in the world to license it for weight loss. In announcing the approval, Julian Beach, Executive Director of Healthcare Quality and Access at the MHRA, stated:
“Having met the MHRA’s rigorous standards of safety, quality and effectiveness, the semaglutide tablet has been approved in the UK for weight loss and weight management.”
The oral Wegovy pill will be available in a range of doses, starting at 1.5 mg and gradually increasing to a maximum maintenance dose of 25 mg per day.

The Wegovy tablet works by mimicking glucagon-like peptide-1 (GLP-1), a naturally produced hormone that regulates appetite, food intake, and blood sugar levels. By acting on the brain regions that control your appetite, oral semaglutide helps reduce hunger, increase fullness, and support long-term weight loss.
For it to be effective, you will need to make lifestyle changes while taking Wegovy. So, you’ll need to follow a calorie-controlled diet and increase physical activity.
Because semaglutide is a peptide medicine that would normally be broken down in the stomach, the tablet has a special absorption-enhancing ingredient called salcaprozate sodium (SNAC). This is designed to protect the medicine from stomach acid, so it has enough time to be absorbed into the bloodstream.
There are also some very strict instructions you must follow when you take the oral Wegovy pill. You must:
If you do not follow these instructions carefully, the Wegovy tablet may be ineffective because it may not be absorbed into the bloodstream.
The OASIS 4 clinical trial shows that the maximum 25 mg dose can help you lose between 13.6% and 16.6% of your starting body weight after 64 weeks. In the trial, the average weight loss amongst all participants, regardless of whether they reduced their dose, had side effects, or dropped out of the trial, was 13.6%. However, when only those who fully adhered to and completed the trial are considered, the average weight loss was 16.6% over 64 weeks.

In the trial, people given the Wegovy tablet were significantly more likely to lose at least 5%, 10%, 15%, or 20% of their body weight than those given a placebo, making it an effective oral weight loss treatment.
A secondary analysis of the OASIS 4 trial found that 28.8% of people on the 25 mg Wegovy pill were considered early responders, achieving at least 10% body weight loss by week 16. These individuals subsequently lost an average of 21.6% by week 64. In addition, people who lost at least 7.5% of their starting weight by week 16 went on to lose an average of 20.3% by week 64. The trial also found that oral semaglutide results in faster weight loss than placebo, with the average time to achieve at least 5% weight loss being 12 weeks, compared to 40 weeks with placebo.

Wegovy tablets will be available privately with a prescription from UK-registered pharmacies, such as Prescription Doctor, and from clinics following a consultation with a clinician. It cannot be acquired without a prescription from a healthcare professional and will not yet be available on the NHS as it has not been approved by the National Institute for Health and Care Excellence (NICE).
The Wegovy tablet will be available for adults who have a body mass index (BMI) of:
You must purchase weight loss medication only from regulated UK pharmacies registered with the General Pharmaceutical Council (GPhC).
Although the Wegovy pill has been approved, it is not yet available to buy. We are expecting this to happen in July or August. Exact launch dates may vary between providers depending on supply availability and stock allocation.
Novo Nordisk, the manufacturer of the Wegovy pill, has not yet announced a nationwide launch schedule. However, industry expectations suggest that availability will follow within weeks of approval, similar to launches in other markets.
No, the Wegovy tablet will not be available on the NHS yet. Although it has received MHRA approval, the Wegovy tablet must undergo NICE approval before routine NHS funding can be considered.
The process evaluates whether a medication offers sufficient clinical benefit and value for money for use in the NHS. Until it is approved by NICE, people who wish to access the Wegovy tablet will need to do so via a private prescription.
Even if the Wegovy pill becomes available on the NHS, it is likely to be limited to people who first meet specific NHS eligibility criteria, similar to the Wegovy injection pen.
At present, the official UK pricing for the Wegovy tablet has not been announced. However, pricing is expected to be similar to Wegovy injections, although final costs may vary across providers and dosage strengths.
Some of the factors that will affect the overall pricing of the Wegovy pill include:
More information about the cost of the Wegovy tablet is expected closer to launch.
Yes, although the Wegovy tablet and Wegovy injection both contain semaglutide as their active ingredient and work in the same way, there are differences in how they are administered, dosing schedules, and how often you need to take them. One thing that remains the same is that they both require you to make healthy lifestyle changes to be effective.
Characteristic | Wegovy Pill | Wegovy Injection |
|---|---|---|
Active ingredient | Semaglutide | Semaglutide |
Method of administration | Oral tablet | Subcutaneous injection |
Frequency | Once daily | Once weekly |
Starting dose | 1.5 mg | 0.25 mg |
Maintenance dose | 25 mg daily | 1.7, 2.4, or 7.2 mg weekly |
Storage | No special storage temperature instructions | Refrigerate before 1st use, then keep refrigerated or at room temperature |
Needle required? | No | Yes |
Prescription only? | Yes | Yes |
The main differences between Wegovy pills and Wegovy injections are:
The most obvious difference between the Wegovy tablet and the injection is the route of administration. Wegovy tablets are swallowed whole, once daily with no more than 120 ml of water, while Wegovy injections are administered under the skin using a pre-filled injection once per week. For people who do not like needles or feel uncomfortable self-injecting, the tablet may offer a more convenient alternative.
The dosing schedules for the Wegovy pill and injection are different. However, they both start on a low dose to help your body adapt to the new medication and reduce the risk of side effects.
The Wegovy injection has a starting dose of 0.25 mg once weekly, which is titrated every 4 weeks until you reach a maintenance dose that is most suitable for you. The dosing schedule for the Wegovy pen is as follows:

The Wegovy pill, on the other hand, has a starting dose of 1.5 mg per day, which increases every month (30 days) until you reach the maximum maintenance dose of 25 mg per day.

The oral Wegovy pill comes with stricter administration instructions than the injections. It must be taken on an empty stomach with no more than 120 ml of water, and you must wait at least 30 minutes before eating, drinking, or taking any other medications. Wegovy injections have fewer restrictions and can be administered at any time of the day with or without food, as long as they are taken on the same day each week.
The most common side effects of the Wegovy injection and tablet are similar. They are:
The Wegovy pill can also cause an upset stomach or indigestion. Most people experience these side effects when they first start treatment or after each dose increase. They are often mild and improve as your body gets used to semaglutide. However, if you experience any side effects that are difficult to manage or worsen, contact your doctor for advice.

The Wegovy tablet has no special storage temperature requirements, making it particularly convenient for travel. Wegovy injection pens have specific storage instructions. They require refrigeration before first use, although they can be stored at room temperature for a limited period once in use. For frequent travellers, the tablet may be the more practical option.
Both the Wegovy tablet and Wegovy injections are effective for weight loss when combined with a healthy diet and regular physical activity. Patients who prefer a needle-free option may favour the tablet, while those looking for the convenience of once-weekly dosing may prefer injections. A clinician can help determine which treatment is most suitable based on your medical history, lifestyle, and weight loss goals.
A more detailed comparison between Wegovy pills and injections is available on our website.
Current evidence from clinical trials suggests that the Wegovy tablet can deliver significant weight loss results comparable to those of Wegovy injections when taken correctly and consistently. However, there has not been a trial that directly compares the effectiveness of the Wegovy pill and the Wegovy injection.
The OASIS 4 trial, which investigated the effectiveness of a 25 mg oral Wegovy pill, found that after 64 weeks, the average weight loss ranged from 14% to 17%. In the STEP UP trial, the maximum maintenance Wegovy injection dose of 7.2 mg resulted in an average weight loss of 20.7%.
How much weight you will lose on Wegovy depends on several factors, such as adherence, lifestyle, and dosage. The tablet requires a higher dose because some of the medication is lost during digestion, whereas injectable semaglutide enters the bloodstream directly. Despite this difference, clinical trials have shown very similar overall weight loss outcomes.
For many patients, the decision may come down to personal preference rather than effectiveness.
Yes, it may be possible to switch from an existing injectable weight loss medication, such as Wegovy or Mounjaro, to the Wegovy oral tablet, provided the switch is approved by a clinician. They will also determine your starting dose of Wegovy tablets, depending on the strength of your current treatment and how you are responding to the medication.
The doses of the Wegovy pill and injection are not biologically equivalent, so a clinician will tell you which is the safest Wegovy tablet dose to begin your treatment on.
The table below outlines our policy when it comes to what your starting dose of the new Wegovy pills could be:
Current Injection Dose | Starting Tablets Dose |
|---|---|
0.25 mg | 4 mg |
0.5 mg | 4 mg |
1 mg | 4 mg or 9 mg depending on side effects |
1.7 mg | 9 mg |
2.4 mg | 25 mg |
7.2 mg | 25 mg |
Your clinician will advise you on the best way to switch to the Wegovy tablet to ensure everything is safe and suitable for your circumstances.
One of the most important things to remember when considering a medicated weight loss programme is that everyone’s journey is different. While clinical trials can imply a certain level of progress, some individuals may take a bit longer to achieve similar results, while others may have different goals altogether. The crucial thing is that you do it your own way.
Prescription Doctor is here to help with this. We’re with you every step of the way, from assessing whether your chosen medication is suitable for your circumstances to regularly checking in with you to ensure your journey is progressing well. You can also seek advice from our experienced clinicians any time you have a query about your treatment schedule.
We’ve made it our mission to simplify access to healthcare, which is why you can start a consultation online at any time from your own home. There’s no need to make an appointment. Once your order is approved, our General Pharmaceutical Council-registered pharmacy will dispense your medication in plain, discreet packaging. Anything approved before 3pm on a weekday is also eligible for next-day delivery to your chosen address; it’s that straightforward. It’s therefore no surprise that we’ve cultivated a strong reputation for the quality of our service.
Ready to make the first move? Discover more about the Wegovy oral tablet or start a weight loss consultation with Prescription Doctor today.
Sources
© 2013 - 2026 Al Muhsineen Limited. All Rights Reserved. Registered Pharmacy: 34 Halliwell Road, Bolton BL1 8RL. Registered Office: 254 First Floor, Shearbrow, Blackburn, England, BB1 8DS
